Skip Navigation

European Heart Journal 1989 10(1):48-54;
Copyright © 1989 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by SYLVÈN, C.
Right arrow Articles by EDLUND, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SYLVÈN, C.
Right arrow Articles by EDLUND, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 The European Society of Cardiology

Angina pectoris-like pain provoked by i.v. bolus of adenosine: Relationship to coronary sinus blood flow, heart rate and blood pressure in healthy volunteers

C. SYLVÈN*,, B. JONSON{dagger} and A. EDLUND{ddagger}

*Departments of Medicine Huddinge Hospital Stockholm Sweden
{dagger}Clinical Pharmacology Huddinge Hospital Stockholm Sweden
{ddagger}Clinical Physiology Huddinge Hospital Stockholm Sweden

Received 11 January 1988; revised 24 May 1988; .

Correspondence. Christer Sylvèn, MD PhD, Department of Medicine, Huddinge Hospital. S-141 86 Huddinge, Sweden.

Abstract

After finding the maximum tolerated i.v. bolus dose of adenosine, three fractions of this dose were given randomly to five volunteers in a double-blind manner. Pain, estimated by a 10-graded category-ratio scale, ECG and coronary sinus blood flow (CSBF), measured by thermodilution and intra-arterial blood pressure, were continuously recorded. At the highest tolerated dose (10.3 ± 2.3 mg), the ECG showed short lasting (<5 s) A V-block but no ischaemic signs. Following the maximum dose, pain started 15 ± 2s after injection, reached a maximum (median 6 of10 grades) after 25 ± 4 s and disappeared after 62 ± 7s. Basal CSBF was 84 + 14 ml min-1, and increased to 297 ± 48 ml/min. The rise in CSBF started 2.4 ± 0.8 s before pain appeared (P <0.005), but reached its peak 18 ± 2s after maximum pain (P <0.005). Although maximum coronary vasodilation was induced at the lowest dose of adenosine given—1/3 of the maximum dose—chest pain increased in a dose-dependent manner. When A V-block did not occur, diastolic pressure did not change from baseline, while systolic blood pressure increased by 5 ± 2% (ANO VA, P < 0.0001) and heart rate increased by 40 ± 7% (ANOVA, P <00001). Following AV-block, except for a decrease of short duration in heart rate and systolic and diastolic blood pressures, the responses were similar. In conclusion, the vasodilator adenosine given as am i. v. bolus to human volunteers who were awake increased heart rate and systolic blood pressure with unchanged diastolic pressure. Adenosine also provoked chest pain, which began shortly after the initial increase of CSBF but showed a more transient time profile. The results are compatible with myocardial origin for the pain by a mechanism different from vasodilation.

Key Words: Adenosine • chest pain • angina pectoris • coronary sinus • ECG • heart rate • volunteers


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. F Bellamy, J. Goodfellow, A. C Tweddel, F. D.J Dunstan, M. J Lewis, and A. H Henderson
Syndrome X and endothelial dysfunction
Cardiovasc Res, November 1, 1998; 40(2): 410 - 417.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Crea and A. Gaspardone
New Look to an Old Symptom: Angina Pectoris
Circulation, November 18, 1997; 96(10): 3766 - 3773.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.